L. Bjerkenstedt

1.8k total citations
50 papers, 1.4k citations indexed

About

L. Bjerkenstedt is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, L. Bjerkenstedt has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 19 papers in Cellular and Molecular Neuroscience and 15 papers in Molecular Biology. Recurrent topics in L. Bjerkenstedt's work include Schizophrenia research and treatment (16 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Amino Acid Enzymes and Metabolism (10 papers). L. Bjerkenstedt is often cited by papers focused on Schizophrenia research and treatment (16 papers), Neurotransmitter Receptor Influence on Behavior (12 papers) and Amino Acid Enzymes and Metabolism (10 papers). L. Bjerkenstedt collaborates with scholars based in Sweden, Denmark and Germany. L. Bjerkenstedt's co-authors include Göran Sedvall, Gunnar Edman, Frits‐Axel Wiesel, Lars Hagenfeldt, F.‐A. Wiesel, Lena Flyckt, Nikolaos Venizelos, Bo Gullberg, Gabriel Oxenstierna and C. Härnryd and has published in prestigious journals such as Biological Psychiatry, Journal of Neurochemistry and The British Journal of Psychiatry.

In The Last Decade

L. Bjerkenstedt

50 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Bjerkenstedt Sweden 23 713 461 355 282 199 50 1.4k
Don Goff United States 10 596 0.8× 471 1.0× 300 0.8× 161 0.6× 195 1.0× 13 1.3k
F.‐A. Wiesel Sweden 28 830 1.2× 764 1.7× 375 1.1× 223 0.8× 244 1.2× 46 2.0k
David L. Garver United States 28 988 1.4× 591 1.3× 430 1.2× 355 1.3× 259 1.3× 82 2.3k
Takahiro Shinkai Japan 24 700 1.0× 524 1.1× 441 1.2× 201 0.7× 62 0.3× 71 1.5k
Morozova Ma Russia 13 628 0.9× 711 1.5× 550 1.5× 230 0.8× 170 0.9× 64 1.5k
Smulevich Ab Russia 11 517 0.7× 596 1.3× 428 1.2× 182 0.6× 116 0.6× 72 1.3k
Mitsutaka Nakamura Japan 20 567 0.8× 725 1.6× 373 1.1× 146 0.5× 189 0.9× 60 1.5k
Lian Yuan Cao China 19 522 0.7× 336 0.7× 231 0.7× 915 3.2× 77 0.4× 22 1.6k
W. Schmid‐Burgk Switzerland 12 316 0.4× 538 1.2× 272 0.8× 269 1.0× 241 1.2× 18 976
Ian Schapkaitz Australia 12 743 1.0× 204 0.4× 179 0.5× 893 3.2× 190 1.0× 14 1.5k

Countries citing papers authored by L. Bjerkenstedt

Since Specialization
Citations

This map shows the geographic impact of L. Bjerkenstedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Bjerkenstedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Bjerkenstedt more than expected).

Fields of papers citing papers by L. Bjerkenstedt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Bjerkenstedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Bjerkenstedt. The network helps show where L. Bjerkenstedt may publish in the future.

Co-authorship network of co-authors of L. Bjerkenstedt

This figure shows the co-authorship network connecting the top 25 collaborators of L. Bjerkenstedt. A scholar is included among the top collaborators of L. Bjerkenstedt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Bjerkenstedt. L. Bjerkenstedt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Comasco, Erika, Lena Flyckt, Tommy Lewander, et al.. (2016). Genetic and Functional Study of <smlcap>L</smlcap>-Type Amino Acid Transporter 1 in Schizophrenia. Neuropsychobiology. 74(2). 96–103. 8 indexed citations
2.
Landgren, Magnus, et al.. (2011). Altered tryptophan and alanine transport in fibroblasts from boys with attention-deficit/hyperactivity disorder (ADHD): an in vitro study. Behavioral and Brain Functions. 7(1). 40–40. 24 indexed citations
3.
Bjerkenstedt, L., et al.. (2009). Aberrant amino acid transport in fibroblasts from patients with bipolar disorder. Neuroscience Letters. 457(1). 49–52. 16 indexed citations
4.
Wiesel, Frits‐Axel, et al.. (2008). Functional characterization of tyrosine transport in fibroblast cells from healthy controls. Neuroscience Letters. 434(1). 56–60. 21 indexed citations
5.
Olsson, Emma, Frits‐Axel Wiesel, L. Bjerkenstedt, & Nikolaos Venizelos. (2005). Tyrosine transport in fibroblasts from healthy volunteers and patients with schizophrenia. Neuroscience Letters. 393(2-3). 211–215. 12 indexed citations
6.
Bjerkenstedt, L., Lars Farde, Lars Terenius, et al.. (2005). Support for limited brain availability of tyrosine in patients with schizophrenia. The International Journal of Neuropsychopharmacology. 9(2). 247–247. 16 indexed citations
7.
Bjerkenstedt, L., Gunnar Edman, R. G. Alken, & Marcus Mannel. (2004). Hypericum extract LI 160 and fluoxetine in mild to moderate depression. European Archives of Psychiatry and Clinical Neuroscience. 255(1). 40–47. 51 indexed citations
8.
Wiesel, F.‐A., Gunnar Edman, Lena Flyckt, et al.. (2004). Kinetics of tyrosine transport and cognitive functioning in schizophrenia. Schizophrenia Research. 74(1). 81–89. 21 indexed citations
9.
Jönsson, Erik G., Lena Flyckt, E. Omer Burgert, et al.. (2003). Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis. Psychiatric Genetics. 13(1). 1–12. 89 indexed citations
10.
Jönsson, Erik G., E. Omer Burgert, Marc‐Antoine Crocq, et al.. (2002). Association study between dopamine D3 receptor gene variant and personality traits. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 117B(1). 61–65. 18 indexed citations
11.
Flyckt, Lena, Nikolaos Venizelos, Gunnar Edman, et al.. (2001). Aberrant Tyrosine Transport Across the Cell Membrane in Patients With Schizophrenia. Archives of General Psychiatry. 58(10). 953–953. 35 indexed citations
12.
Flyckt, Lena, Jörgen Borg, Kristian Borg, et al.. (2000). Muscle biopsy, macro EMG, and clinical characteristics in patients with schizophrenia. Biological Psychiatry. 47(11). 991–999. 24 indexed citations
13.
Flyckt, Lena, et al.. (2000). Muscle biopsy, macro EMG and clinical characteristics in patients with schizophrenia. Schizophrenia Research. 41(1). 156–156. 2 indexed citations
14.
Wiesel, Frits‐Axel, Jesper Andersson, Göran Westerberg, et al.. (1999). Tyrosine transport is regulated differently in patients with schizophrenia. Schizophrenia Research. 40(1). 37–42. 21 indexed citations
15.
Wiesel, F.‐A. & L. Bjerkenstedt. (1996). Tyrosine transport as an indicator of cell membrane dysfunction in schizophrenia. Prostaglandins Leukotrienes and Essential Fatty Acids. 55(1-2). 55–58. 3 indexed citations
16.
Wiesel, F.‐A., Nikolaos Venizelos, L. Bjerkenstedt, & Lars Hagenfeldt. (1994). Tyrosine transport in schizophrenia. Schizophrenia Research. 13(3). 255–258. 17 indexed citations
17.
Baastrup, P. C., L. Bjerkenstedt, S. J. Dencker, et al.. (1993). A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis. Acta Psychiatrica Scandinavica. 87(1). 48–58. 32 indexed citations
18.
Bjerkenstedt, L.. (1989). Melperone in the treatment of schizophrenia. Acta Psychiatrica Scandinavica. 80(S352). 35–39. 17 indexed citations
19.
Bjerkenstedt, L., et al.. (1985). Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. European Journal of Clinical Pharmacology. 28(5). 553–557. 73 indexed citations
20.
Sedvall, Göran, et al.. (1977). Mass fragmentography to study dopamine metabolism.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16. 343–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Don Goff Breakdown of academic impact, for papers by F.‐A. Wiesel Breakdown of academic impact, for papers by David L. Garver Breakdown of academic impact, for papers by Takahiro Shinkai Breakdown of academic impact, for papers by Morozova Ma Breakdown of academic impact, for papers by Smulevich Ab Breakdown of academic impact, for papers by Mitsutaka Nakamura Breakdown of academic impact, for papers by Lian Yuan Cao Breakdown of academic impact, for papers by W. Schmid‐Burgk Breakdown of academic impact, for papers by Ian Schapkaitz
Rankless by CCL
2026